pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
Novel Molecules for Glioma
Glioma
$MRK
Merck & Co., Inc.
Preclinical
Novel Therapeutic
Glioblastoma Multiforme (GBM)
Rosalind Franklin University of Medicine and Science
Phase 2
NovoCardia
Congestive Heart Failure (Heart Failure)
Help Therapeutics
Phase 2
← prev
page 116 of 231
next →
131
Pain
89
Neurology
1
Nu-3
Diabetic Foot Ulcers
Lakewood-Amedex Inc
Phase 2
NuGel
Atopic Dermatitis (Atopic Eczema)
Hudson Therapeutics Inc
Preclinical
Nubytide
Alzheimer's Disease
Cenna Biosciences Inc
Preclinical
NvA-011
Dystrophic Epidermolysis Bullosa
Nova Anchora LLC
Phase 2
OA-SYS
Osteoarthritis
Ageless Biotech Inc
Phase 2
OATD-01
Pulmonary Sarcoidosis
Molecure SA
Phase 2
OBI-902
Bile Duct Cancer (Cholangiocarcinoma)
OBI Pharma Inc
Phase 2
OBX-115
Metastatic Melanoma
Obsidian Therapeutics Inc
Phase 1
OCF-001
Vulvovaginal Candidiasis
Sano Chemicals Inc
Preclinical
OCF-203
Idiopathic Pulmonary Fibrosis
$OCEA
Ocean Biomedical, Inc.
Preclinical
OCT-130401
Trigeminal Neuralgia (Tic Douloureux)
Oxford Cannabinoid Technologies Ltd
Phase 1
OCU-200
Diabetic Macular Edema
$OCGN
Ocugen, Inc.
Phase 2
OCU-410
Geographic Atrophy
$OCGN
Ocugen, Inc.
Phase 3
OCU-410ST
Juvenile Macular Degeneration (Stargardt Disease)
$OCGN
Ocugen, Inc.
Preclinical
OCU-510
Seasonal Influenza
$OCGN
Ocugen, Inc.
Preclinical
OCU-520
Coronavirus Disease 2019 (COVID-19)
$OCGN
Ocugen, Inc.
Preclinical
OCX-410
Non-Small Cell Lung Carcinoma
$OCEA
Ocean Biomedical, Inc.
Preclinical
OCX-909
Glioblastoma Multiforme (GBM)
$OCEA
Ocean Biomedical, Inc.
Preclinical
OFXO-11
Osteoporosis
OssiFi Inc
OGIVRI
OGIVRI (TRASTUZUMAB-DKST)
no indication
MYLAN GMBH
Preclinical
OKI-345
Breast Cancer
$OKUR
OnKure Therapeutics, Inc.
Preclinical
OKI-355
Cardiovascular Disease
$OKUR
OnKure Therapeutics, Inc.
OLANZAPINE AND FLUOXETINE
OLANZAPINE AND FLUOXETINE
no indication
TEVA PHARMS
OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION
OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION
no indication
BAUSCH AND LOMB INC
Phase 1
OLX-07010
Alzheimer's Disease
Oligomerix inc
Phase 2
OLX-101A
Hypertrophic Scars
OliX Pharmaceuticals Inc
Phase 1
OLX-301A
Dry (Atrophic) Macular Degeneration
Laboratoires Thea SA
